NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
Australia flag Australia · Delayed Price · Currency is AUD
0.1400
+0.0100 (7.69%)
Jul 4, 2025, 4:10 PM AEST

ASX:NSB Statistics

Total Valuation

ASX:NSB has a market cap or net worth of AUD 46.56 million. The enterprise value is 42.07 million.

Market Cap 46.56M
Enterprise Value 42.07M

Important Dates

The next estimated earnings date is Monday, August 25, 2025.

Earnings Date Aug 25, 2025
Ex-Dividend Date n/a

Share Statistics

ASX:NSB has 332.58 million shares outstanding. The number of shares has increased by 1.15% in one year.

Current Share Class 332.58M
Shares Outstanding 332.58M
Shares Change (YoY) +1.15%
Shares Change (QoQ) +1.89%
Owned by Insiders (%) 9.30%
Owned by Institutions (%) 2.75%
Float 267.93M

Valuation Ratios

The trailing PE ratio is 17.28.

PE Ratio 17.28
Forward PE n/a
PS Ratio 21.05
PB Ratio 9.34
P/TBV Ratio 10.03
P/FCF Ratio n/a
P/OCF Ratio 40.25
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 35.45
EV / Sales 19.02
EV / EBITDA 38.21
EV / EBIT 41.80
EV / FCF n/a

Financial Position

The company has a current ratio of 179.30

Current Ratio 179.30
Quick Ratio 175.69
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 341.03

Financial Efficiency

Return on equity (ROE) is 26.99% and return on invested capital (ROIC) is 14.31%.

Return on Equity (ROE) 26.99%
Return on Assets (ROA) 14.08%
Return on Invested Capital (ROIC) 14.31%
Return on Capital Employed (ROCE) 20.20%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.49
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +268.42% in the last 52 weeks. The beta is 1.32, so ASX:NSB's price volatility has been higher than the market average.

Beta (5Y) 1.32
52-Week Price Change +268.42%
50-Day Moving Average 0.06
200-Day Moving Average 0.04
Relative Strength Index (RSI) 81.51
Average Volume (20 Days) 482,608

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, ASX:NSB had revenue of AUD 2.21 million and earned 1.19 million in profits. Earnings per share was 0.01.

Revenue 2.21M
Gross Profit 2.19M
Operating Income 1.01M
Pretax Income 1.19M
Net Income 1.19M
EBITDA 1.10M
EBIT 1.01M
Earnings Per Share (EPS) 0.01
Full Income Statement

Balance Sheet

The company has 4.49 million in cash and n/a in debt, giving a net cash position of 4.49 million or 0.01 per share.

Cash & Cash Equivalents 4.49M
Total Debt n/a
Net Cash 4.49M
Net Cash Per Share 0.01
Equity (Book Value) 4.98M
Book Value Per Share 0.03
Working Capital 4.64M
Full Balance Sheet

Cash Flow

Operating Cash Flow 1.16M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 98.98%, with operating and profit margins of 45.50% and 53.66%.

Gross Margin 98.98%
Operating Margin 45.50%
Pretax Margin 53.66%
Profit Margin 53.66%
EBITDA Margin 49.77%
EBIT Margin 45.50%
FCF Margin n/a

Dividends & Yields

ASX:NSB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.15%
Shareholder Yield n/a
Earnings Yield 2.55%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ASX:NSB has an Altman Z-Score of 136.04 and a Piotroski F-Score of 5.

Altman Z-Score 136.04
Piotroski F-Score 5